Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/1996
11/12/1996US5574173 Inhibitors of tumor necrosis factor
11/12/1996US5574045 Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
11/12/1996US5574034 Treatment of immune diseases and excess cell proliferation, enzyme inhibitors
11/12/1996US5573764 Use of interleukin-12 to prevent graft versus host disease
11/12/1996CA2017507C Adjuvant formulation comprising a submicron oil droplet emulsion
11/10/1996CA2175881A1 Vitamin d compounds and methods of preparing these compounds
11/07/1996WO1996034970A1 Improved methods for transfecting t cells
11/07/1996WO1996034969A2 Gene therapy using replication competent targeted adenoviral vectors
11/07/1996WO1996034964A2 Stable variant hk2 polypeptide
11/07/1996WO1996034953A2 Cd16-ii variants
11/07/1996WO1996034943A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996WO1996034891A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996WO1996034886A1 Compositions and methods for detecting and treating acquired immunodeficiency syndrome
11/07/1996WO1996034883A1 Acellular pertussis vaccines and methods of preparation thereof
11/07/1996WO1996034880A1 Cd6 ligand
11/07/1996WO1996034864A1 Piperazino derivatives as neurokinin antagonists
11/07/1996WO1996034855A1 Fatty acid esters as bioactive compounds
11/07/1996WO1996034846A1 1,3-propane diol derivatives as bioactive compounds
11/07/1996WO1996034626A1 Composition of tyrosine and polymerised allergen
11/07/1996WO1996034623A1 Acellular pertussis vaccines and methods of preparation thereof
11/07/1996WO1996034622A1 Modified myelin protein molecules
11/07/1996WO1996027664A3 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
11/07/1996CA2433502A1 Acellular pertussis vaccines and methods of preparation thereof
11/07/1996CA2220156A1 Human leukocyte 12-lipoxygenase and its role in the pathogenesis of disease states
11/07/1996CA2220123A1 Human chemokine beta-8, chemokine beta-1 and macrophage inflammatory protein-4
11/07/1996CA2220098A1 Cd6 ligand
11/07/1996CA2218858A1 Modified myelin protein molecules
11/07/1996CA2218390A1 Gene therapy using replication competent targeted adenoviral vectors
11/07/1996CA2217388A1 Composition of tyrosine and polymerised allergen
11/06/1996EP0740937A2 Use of retinoids for the manufacture of a pharmaceutical or cosmetic composition
11/06/1996EP0740704A1 Immunization by inoculation of dna transcription unit
11/06/1996EP0740668A1 Tetracyclic derivatives, process of preparation and use
11/06/1996EP0740655A1 Metalloproteinase inhibitors
11/06/1996EP0740653A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
11/06/1996EP0740652A1 Metalloproteinase inhibitors
11/06/1996EP0740550A1 Use of mometasone furoate for treating airway passage and lung diseases
11/06/1996EP0729361A4 Method of treating neurological disorders
11/06/1996CN1135182A Immunoloigcal tolerance-inducting agent
11/06/1996CN1135181A Alteration of immune response using pan Dr-binding peptides
11/06/1996CN1134832A Type 2 enzyme induction agent and method for prepn. of same
11/05/1996US5571818 Pyrrolyl-4h-pyranoisoquinolines
11/05/1996US5571806 Dibenz[b,f][1,4]oxazepin(and thiazepin)-11(10H)-ones and-thiones and their use in the prevention or treatment of HIV infection
11/05/1996US5571798 Synergistic antiviral nucleoside combinations
11/05/1996US5571515 Compositions and methods for use of IL-12 as an adjuvant
10/1996
10/31/1996WO1996034106A1 Decorin binding protein compositions and methods of use
10/31/1996WO1996034105A1 Modified polypeptides for enhanced immunogenicity
10/31/1996WO1996034104A1 Antagonists of human interleukin-6 that are totally incapable of binding gp 130, and their use in the preparation of pharmaceutical compounds
10/31/1996WO1996034095A1 Human tumor necrosis factor receptors
10/31/1996WO1996034005A1 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody mbr1 and uses thereof
10/31/1996WO1996033739A1 Vaccines containing a saponin and a sterol
10/31/1996WO1996033734A1 A pluripotent vaccine against enveloped viruses
10/31/1996WO1996033730A2 Chemokine binding protein and methods of use therefor
10/31/1996WO1996033720A1 Use of (r)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases
10/31/1996CA2219339A1 A pluripotent vaccine against enveloped viruses
10/31/1996CA2218987A1 Modified polypeptides for enhanced immunogenicity
10/31/1996CA2218492A1 Decorin binding protein compositions and methods of use
10/30/1996EP0739892A2 Chromone derivatives
10/30/1996EP0739881A2 Piperidine derivatives
10/30/1996EP0739350A1 Ligand that binds fas antigen
10/30/1996EP0739336A1 Gem-disubstituted azacyclic tachykinin antagonists
10/30/1996EP0739214A1 A METHOD OF TREATMENT OF PARASITIC INFECTION USING IgE ANTAGONISTS
10/30/1996EP0739212A1 Use of interleukin-12 to prevent graft versus host disease
10/30/1996EP0532595B1 The pharmacological use of certain cystine derivatives
10/30/1996CN1134705A Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
10/30/1996CN1134419A N-(3-Benzofuranyl) urea-derivatives
10/30/1996CN1134270A Center dispense suture package
10/29/1996US5569665 Peptidyl derivatives and their use as metalloproteinases inhibitors
10/29/1996US5569462 Placing a population of therapeutic substance producing cells into cell receiving chamber of immunoisolation apparatus, implanting apparatus into patient, administering an immunomodulatory agent
10/29/1996US5569454 Methods of treating infection using natural killer stimulatory factor
10/29/1996CA2063727C Method of preventing graft rejection in solid organ transplantation
10/25/1996EP0712936A4 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it
10/24/1996WO1996033282A2 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/24/1996WO1996033281A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations
10/24/1996WO1996033268A1 Apopain
10/24/1996WO1996033208A1 Antibody purification by low-ph hydrophobic interaction chromatoggraphy
10/24/1996WO1996033203A1 Immunopotentiating inosine monophosphate 5'-nucleotidase resistant derivatives and uses thereof
10/24/1996WO1996033185A1 A process for preparing form 1 ranitidine hydrochloride
10/24/1996WO1996033181A1 Ethynylthiazole derivative
10/24/1996WO1996033172A1 Arylsulfonyl hydroxamic acid derivatives as mmp and tnf inhibitors
10/24/1996WO1996033166A1 Hydroxamic and carboxylic acids as metalloprotease inhibitors
10/24/1996WO1996033165A1 Derivatives of succinamide and their use as metalloproteinase inhibitor
10/24/1996WO1996033161A1 Derivatives of succinamide and their use as metalloproteinase inhibitors
10/24/1996WO1996032965A1 Cd45rb binding compounds for the prevention of transplant rejection
10/24/1996WO1996032963A1 Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins
10/24/1996WO1996029315A3 Imidazole derivatives as histamine receptor h3 (ant)agonists
10/24/1996CA2218679A1 Apopain
10/24/1996CA2218562A1 A process for preparing form 1 ranitidine hydrochloride
10/24/1996CA2218385A1 Induction and enhancement of the immune response to polysaccharides with bacterial lipoproteins
10/24/1996CA2218380A1 Novel hydroxamic and carbocylic acids as metalloprotease inhibitors
10/24/1996CA2216871A1 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations
10/24/1996CA2216868A1 High efficiency ex vivo transduction of hematopoietic stem cells by recombinant retroviral preparations
10/23/1996EP0738736A1 Monoclonal antibodies to gp130, and their uses
10/23/1996EP0738715A2 Arylalkyl-pyridazinones
10/23/1996EP0738328A1 Composition containing nucleic acids, preparation and uses
10/23/1996EP0738322A1 T cell antigen receptor v region proteins and methods of preparation thereof
10/23/1996EP0738281A1 Peptides and methods against psoriasis
10/23/1996EP0738270A1 Dihydro pyrazolopyrroles
10/23/1996EP0738269A1 Novel piperidine derivatives with paf antagonist activity
10/23/1996EP0629213B1 Use of an immunostimulatory agent
10/23/1996EP0528886B1 Beta cell antigen
1 ... 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 ... 1172